Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Aurobindo Dolutegravir

AuroBindo Logo

Aurobindo Pharma, along with Mylan Laboratories, received support from the foundation to expand the distribution of a single-pill HIV treatment containing dolutegravir to low- and middle-income populations at a low price. This treatment is part of a global effort to provide everyone living with HIV with high-quality antiretroviral therapy.

Investment Date: July 2017

Press Release
Case Study